Treatment of neurogenic detrusor hyperactivity:: enterocystoplasty

被引:13
|
作者
Game, X. [1 ]
Karsenty, G.
Chartier-Kastler, E.
Ruffion, A.
机构
[1] Ctr Hosp Univ Toulouse, Serv Urol, Toulouse, France
[2] Ctr Hosp Univ Marseille, Serv Urol, Marseille, France
[3] Univ Paris 06, Serv Urol, GH Pitie Salpetriere, Paris, France
[4] UCBL Lyon 1, Ctr Hosp Lyon Sud, Serv Urol Lyon Sud, Lyon, France
来源
PROGRES EN UROLOGIE | 2007年 / 17卷 / 03期
关键词
neurogenic bladder; spinal cord injury; enterocystoplasty; bladder augmentation; incontinence;
D O I
10.1016/S1166-7087(07)92373-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The importance of a good capacity bladder reservoir able to fill at low pressure has now been clearly established. These properties have a double advantage: they ensure urinary continence and prevent damage to the upper urinary tract. In the case of failure of the various medical treatments, including botulinum toxin injections, surgical bladder augmentation can be considered, especially in the presence of poor bladder compliance. The authors present the technical details of bladder augmentation by enterocystoplasty or by alternative techniques and their medium- and long-term results, and define the postoperative surveillance of this type of surgery.
引用
收藏
页码:584 / 596
页数:13
相关论文
共 50 条
  • [1] Treatment of neurogenic detrusor hyperactivity: detrusor myomectomy
    Karsenty, G.
    Vidal, F.
    Ruffion, A.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2007, 17 (03): : 580 - 583
  • [2] Pharmacological treatment of neurogenic detrusor hyperactivity: intrathecal drugs
    Denys, P.
    Schneider, A. Even
    Remy-Neris, O.
    Ben-Smail, D.
    Chartier-Kastler, E.
    Ruffion, A.
    Bussel, B.
    PROGRES EN UROLOGIE, 2007, 17 (03): : 564 - 567
  • [3] Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI
    Anquetil, C.
    Abdelhamid, S.
    Gelis, A.
    Fattal, C.
    SPINAL CORD, 2016, 54 (11) : 1031 - 1035
  • [4] Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI
    C Anquetil
    S Abdelhamid
    A Gelis
    C Fattal
    Spinal Cord, 2016, 54 : 1031 - 1035
  • [5] Treatment of neurogenic detrusor hyperactivity: surgical methods of bladder denervation
    Ruffion, A.
    Mertens, P.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2007, 17 (03): : 576 - 579
  • [6] Seven years of botulinum toxin type A in the treatment of neurogenic detrusor hyperactivity
    Stoehrer, M.
    Wolff, A.
    Kramer, G.
    Steiner, R.
    Loechner-Ernst, D.
    Leuth, D.
    Steude, U.
    Ruebben, H.
    UROLOGE, 2007, 46 (09): : 1211 - 1218
  • [7] A systematic review of the diagnosis and treatment of patients with neurogenic hyperactivity of the detrusor muscle
    Borau, A.
    Adot, J. M.
    Allue, M.
    Artandis, S.
    Castro, D.
    Esteban, M.
    Satinas, J.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (01): : 5 - 16
  • [8] Pharmacological treatment of neurogenic detrusor hyperactivity:: oral, patch, intravesical instillation
    de Seze, M.
    Ruffion, A.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2007, 17 (03): : 559 - 563
  • [9] Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections
    Karsenty, G.
    Corcos, J.
    Schurch, B.
    Ruffion, A.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2007, 17 (03): : 568 - 575
  • [10] DIAGNOSIS OF DETRUSOR HYPERACTIVITY IN CHILDREN WITH NEUROGENIC BLADDER
    NAGLO, AS
    NERGARDH, A
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1981, 15 (02): : 91 - 96